Corrigendum to "Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk" [Immunology Letters 254 (2023) 1-5]

Immunol Lett. 2023 Jul 17:S0165-2478(23)00115-3. doi: 10.1016/j.imlet.2023.07.002. Online ahead of print.NO ABSTRACTPMID:37468424 | DOI:10.1016/j.imlet.2023.07.002

Source: Immunology Letters - July 19, 2023 Category: Allergy & Immunology Authors: Shahad W Nussrat Ali H Ad'hiah Source Type: research